中文 | English
Return
Total: 34 , 1/4
Show Home Prev Next End page: GO
MeSH:(Receptors, Vasopressin*)

2.A Case of Hyponatraemic Seizure Following Terlipressin Therapy for a Variceal Hemorrhage in a Patient with Liver Cirrhosis.

Jin Hee KIM ; Ja Kyung KIM ; So Yeong MUN ; Chung Jo CHOI ; Han Min PARK ; Yong Seol JEONG ; Jun Goo KANG

Korean Journal of Medicine 2014;87(3):323-327

3.Increases of cAMP Production and Urinary cAMP Excretion by Oxytocin in the Inner Medullary Collecting Duct(IMCD).

Ki Young NA ; Un Sil JEON ; Kwon Wook JOO ; Woo Seong HUH ; Jung Geon LEE ; Woo Kyung JUNG ; Kang Seock KIM ; Yon Su KIM ; Curie AHN ; Jin Suk HAN ; Suhng Gwon KIM ; Jung Sang LEE

Korean Journal of Nephrology 2000;19(1):58-63

4.Vasopressin and Vasopressin Receptor Antagonists.

Yun Kyu OH

Electrolytes & Blood Pressure 2008;6(1):51-55

5.Genetic analysis of a congenital nephrogenic diabetes insipidus pedigree.

Yunfeng SHEN ; Xiaoyang LAI ; Xinlan XIAO ; Jing LI ; Rong YU ; Hui GAO ; Meiying ZHANG

Chinese Medical Journal 2014;127(6):1089-1092

6.Efficacy of Vaptans for Management of Ascites in Patients with Liver Cirrhosis.

Won Hyeok CHOE ; June Sung LEE

Korean Journal of Medicine 2012;82(1):22-31

7.V2 Receptor Antagonist; Tolvaptan.

Joo Hark YI ; Hyun Jong SHIN ; Ho Jung KIM

Electrolytes & Blood Pressure 2011;9(2):50-54

8.Osmotic Demyelination Syndrome Resulting from an Unexpected Response to Tolvaptan in a Patient with Heart Failure.

Kyehwan KIM ; Min Gyu KANG ; Jeong Rang PARK ; Jin Yong HWANG ; Choong Hwan KWAK

Korean Journal of Medicine 2017;92(1):62-65

9.Genetic diagnosis for a pedigree affected with hereditary nephrogenic diabetes insipidus.

Zhijin LU ; Xia WU ; Renyuan ZHOU ; Kai KAI ; Jie WEN ; Qian XIONG

Chinese Journal of Medical Genetics 2019;36(2):140-142

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 34 , 1/4 Show Home Prev Next End page: GO